Molecular Biology of the Cell click for CBE Life Science Education Page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E08-03-0316 on October 8, 2008

Vol. 19, Issue 12, 5435-5445, December 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Materials
Right arrow All Versions of this Article:
E08-03-0316v1
19/12/5435    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, Z.
Right arrow Articles by Fang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, Z.
Right arrow Articles by Fang, X.

Role of LPA4/p2y9/GPR23 in Negative Regulation of Cell Motility

Zendra Lee*, Ching-Ting Cheng*, Helen Zhang{dagger}, Mark A. Subler{dagger}, Jinhua Wu*, Abir Mukherjee*, Jolene J. Windle{dagger}, Ching-Kang Chen*, and Xianjun Fang*

Departments of *Biochemistry and Molecular Biology and {dagger}Human Genetics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298

Submitted March 26, 2008; Revised August 20, 2008; Accepted September 25, 2008
Monitoring Editor: Carl-Henrik Heldin

Lysophosphatidic acid (LPA) is a ligand of multiple G protein–coupled receptors. The LPA1–3 receptors are members of the endothelial cell differentiation gene (Edg) family. LPA4/p2y9/GPR23, a member of the purinergic receptor family, and recently identified LPA5/GPR92 and p2y5 are structurally distant from the canonical Edg LPA receptors. Here we report targeted disruption of lpa4 in mice. Although LPA4-deficient mice displayed no apparent abnormalities, LPA4-deficient mouse embryonic fibroblasts (MEFs) were hypersensitive to LPA-induced cell migration. Consistent with negative modulation of the phosphatidylinositol 3 kinase pathway by LPA4, LPA4 deficiency potentiated Akt and Rac but decreased Rho activation induced by LPA. Reconstitution of LPA4 converted LPA4-negative cells into a less motile phenotype. In support of the biological relevance of these observations, ectopic expression of LPA4 strongly inhibited migration and invasion of human cancer cells. When coexpressed with LPA1 in B103 neuroblastoma cells devoid of endogenous LPA receptors, LPA4 attenuated LPA1-driven migration and invasion, indicating functional antagonism between the two subtypes of LPA receptors. These results provide genetic and biochemical evidence that LPA4 is a suppressor of LPA-dependent cell migration and invasion in contrast to the motility-stimulating Edg LPA receptors.


This was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-03-0316) on October 8, 2008.

Address correspondence to: Xianjun Fang (xfang{at}vcu.edu).

Abbreviations used: LPA, lysophosphatidic acid; GPCR, G protein–coupled receptor; KO, knockout; MEF, mouse embryonic fibroblast.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. Pamuklar, L. Federico, S. Liu, M. Umezu-Goto, A. Dong, M. Panchatcharam, Z. Fulerson, E. Berdyshev, V. Natarajan, X. Fang, et al.
Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and Thrombosis
J. Biol. Chem., March 13, 2009; 284(11): 7385 - 7394.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2008 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.